![AstraZeneca considers new acquisition](https://www.benefitscanada.com/wp-content/uploads/sites/7/2011/02/drug-benefits-costs-pills.jpg)
British drug maker AstraZeneca is considering acquiring cancer-drug developer Acerta Pharma, which operates in the Netherlands and California, The New York Times reports.
The news comes at a time when the pharmaceutical giant tries to grow its cancer treatment options.
It remains unclear if AstraZeneca will finalize such a deal or what the terms of a potential transaction would be.
Read the full story here.